MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation

PURPOSE: MORC4 has recently been characterized as a breast cancer-associated anti-apoptotic oncoprotein. In the current study, we explored its downstream regulation in luminal A/B breast tumors. MATERIALS AND METHODS: Bioinformatic prediction was performed using data from The Cancer Genome Atlas (TC...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jing, Zeng, Shiyan, Tian, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367747/
https://www.ncbi.nlm.nih.gov/pubmed/32764967
http://dx.doi.org/10.2147/OTT.S260509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367747/
https://www.ncbi.nlm.nih.gov/pubmed/32764967
http://dx.doi.org/10.2147/OTT.S260509

Ejemplares similares